US moves won’t solve vaccine access problem for poor soon: experts

• Washington is trying to position itself as a global leader in vaccine access with a policy shift on IP rules and plans to send more doses overseas
• But a ‘patent waiver doesn’t necessarily increase production capacity’, academic says